<?xml version="1.0" encoding="UTF-8"?>
<p>Remdesivir is a prodrug of the adenosine nucleotide analogue GS‐441524 that incorporates into nascent viral RNA chains, inhibiting virus infection in a human cell line (human liver cancer Huh 7 cells).
 <xref rid="apt15779-bib-0102" ref-type="ref">
  <sup>102</sup>
 </xref>, 
 <xref rid="apt15779-bib-0103" ref-type="ref">
  <sup>103</sup>
 </xref> It appears to be effective against RNA viruses SARS, MERS and Ebola.
 <xref rid="apt15779-bib-0103" ref-type="ref">
  <sup>103</sup>
 </xref> In MERS‐CoV mouse models, it has been found to reduce the virus titre and improve lung tissue damage.
 <xref rid="apt15779-bib-0104" ref-type="ref">
  <sup>104</sup>
 </xref> There are currently multiple phase III studies of remdesivir in COVID‐19 patients.
</p>
